Holding(s) in Company

Summary by AI BETAClose X

The Goldman Sachs Group Inc. has notified Oxford Biomedica PLC of a change in its major holdings, crossing a threshold on September 16, 2026. The firm now holds a total of 5.083440% of voting rights, comprising 0.001408% directly attached to shares and 5.082032% through various financial instruments including securities lending and cash-settled swaps. This notification reflects an acquisition or disposal of voting rights and financial instruments, with the total number of voting rights held amounting to 6,153,493.

Disclaimer*

UK 100

Latest directors dealings